STELLATE THERAPEUTICS
Live / Registered — Registered (as of 03 May 2022)
What this means for you
Registered since 03 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88983879
- Registration number
- 6719570
- Mark type
- Stylized text
- Filed
- 15 Jan 2020
- Published for opposition
- 26 May 2020
- Registered
- 03 May 2022
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; medical and scientific research in the fields of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
Owner
- STELLATE THERAPEUTICS INC., NEW YORK, NY, US
- STELLATE THERAPEUTICS INC., NEW YORK, NY, US
- STELLATE THERAPEUTICS INC., New York, NY, US
- Amabiotics Inc., New York, NY, US
- Amabiotics Inc., New York, NY, US
Prosecution history
- 03 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Mar 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Jan 2022 — USE AMENDMENT FILED
- 21 Jan 2022 — SOU EXTENSION 3 GRANTED
- 21 Jan 2022 — SOU EXTENSION 3 FILED
- 02 Mar 2022 — DIVISIONAL PROCESSING COMPLETE
- 21 Jan 2022 — DIVISIONAL REQUEST RECEIVED
- 21 Jan 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 21 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Jan 2022 — TEAS STATEMENT OF USE RECEIVED
- 16 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2021 — SOU EXTENSION 2 GRANTED